WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Captain Tom's scandalMiami Dolphins bolster pass rush, taking Chop Robinson of Penn State with 21st pick of NFL draftCaptain Tom's scandalHow at least 13 banks may have worked with feds to SPY on transactions of hundreds of proAs some universities negotiate with proAP Week in Pictures: GlobalLions trade up in first round of NFL draft, take Alabama cornerback Terrion ArnoldBrazil's Romário returns to training at age 58, scores twice and keeps sharp tongueStephen Curry wins NBA's Clutch Player of the Year, adding to his trophy collectionAuto industry insiders highlight interdependence between China, Europe
2.3893s , 6604.4921875 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Stellar Standpoint news portal